Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2017-09-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and bioequivalence of Ritonavir
tablet 100 mg versus NORVIR 100 mg tablet in healthy Chinese adult participants under fasting
condition.